Some Names That May Grab Investor Focus: D.R. Horton (DHI), Fossil Group (FOSL), AECOM Technology (ACM), Insys Therapeutics (INSY), Ophthotech Corp (OPHT)

D.R. Horton Inc (DHI), the largest homebuilder in the U.S., will release financial results for its 4Q earnings ended Sept. 30 before the market opens. The Fort Worth, Texas-based company is expected to report earnings of $0.48 per share on revenue of $2.38 billion, higher than the $1.8 billion in revs from a year ago. DR Horton shares fell 1.75 percent to $23.02 in after-hours trading, leaving them up 4.97 percent this year.

Wall Street expects Fossil Group (FOSL) to report third quarter results on Tuesday at 4:30 p.m. ET. Analysts are looking for earnings of $1.82 per share on $879.05 million in revenue. Fossil Group stock ended yesterday’s session up 0.20% to $103.22. It is trading at a 2015 forward price-to-earnings multiple of 12.92x.

Analysts expect AECOM Technology (ACM) to report its Q4 earnings before market open. The engineering company’s consensus is $0.82 per share on revenue of $2.25 billion. Coming into this report, AECOM shares are printing the tape at $32.78, up 6.5% year-over-year and 11.38% year-to-date.

Insys Therapeutics, Inc. (INSY) is reporting financial results for the quarter ending September 30, 2014 prior to market open on Tuesday. Wall Street expects the company to report its Q4 earnings at $0.29 per share on revs of $57.08 million. Insys Therapeutics has an average 30-day trading volume of 505,889 shares. The name has a 52wk range of $20.52 – $57.91. Insys has a current market cap of $1.28B and a t-12 P/E ratio of 25.74.

Ophthotech Corporation (OPHT) is reporting for the quarter ending September 30, before the market opens. The biomedical (gene) company is projected to report its Q3 earnings at ($0.62) per share on revenue of $8.02 million. Ophthotech shares closed down $0.13 Monday to $41.13. In the past 52 weeks, shares of the New York-based firm have traded between a low of $22.61 and a high of $47.99. Shares are up 49.56% year-over-year, and 27.14% year-to-date.

Be the first to comment

Leave a Reply

Your email address will not be published.


*